Literature DB >> 29113184

LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.

Junhua Luo1, Jing Chen2, Hang Li1, Yu Yang1, Haichao Yun1, Shangqi Yang1, Xiangming Mao1.   

Abstract

The long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) is an oncogenic lncRNA in bladder cancer, and its upregulation is associated with enhanced cell invasion. However, the underlying mechanism remains to be elucidated. The present study demonstrated that UCA1 was positively associated with cell invasion ability and promoted epithelial-mesenchymal transition (EMT) of bladder cancer cells by inducing high mobility group box 1 (HMGB1). Furthermore, bioinformatics and luciferase reporter assays demonstrated binding sites of the tumor suppressive miR-143 within UCA1 and the 3'untranslated region of HMGB1. UCA1 negatively regulated miR-143 expression in a dose-dependent manner in bladder cancer cells. In addition, UCA1 and HMGB1 were upregulated and miR-143 was downregulated in bladder cancer specimens. Overall, the data suggested that UCA1 may promote the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway, which exhibits an important regulatory role in the pathology of bladder cancer.

Entities:  

Keywords:  bladder cancer; epithelial-mesenchymal transition; high mobility group box 1; miR-143; urothelial carcinoma associated 1

Year:  2017        PMID: 29113184      PMCID: PMC5662909          DOI: 10.3892/ol.2017.6886

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions.

Authors:  M I Mosevitsky; V A Novitskaya; M G Iogannsen; M A Zabezhinsky
Journal:  Eur J Biochem       Date:  1989-11-06

3.  Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma.

Authors:  Hui-Min Wang; Jian-Hong Lu; Wen-Yi Chen; Ai-Qin Gu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses.

Authors:  Hideyuki Yanai; Tatsuma Ban; ZhiChao Wang; Myoung Kwon Choi; Takeshi Kawamura; Hideo Negishi; Makoto Nakasato; Yan Lu; Sho Hangai; Ryuji Koshiba; David Savitsky; Lorenza Ronfani; Shizuo Akira; Marco E Bianchi; Kenya Honda; Tomohiko Tamura; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Nature       Date:  2009-11-05       Impact factor: 49.962

5.  Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer.

Authors:  Beibei Ni; Xihu Yu; Xiaoyan Guo; Xinjuan Fan; Zihuan Yang; Peihuang Wu; Zixu Yuan; Yanhong Deng; Jianping Wang; Dianke Chen; Lei Wang
Journal:  Int J Oncol       Date:  2015-07-29       Impact factor: 5.650

Review 6.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

7.  LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma.

Authors:  Yanping Wei; Qianqian Sun; Lindong Zhao; Jianbo Wu; Xiaonan Chen; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Med Oncol       Date:  2016-07-07       Impact factor: 3.064

8.  Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.

Authors:  Guillaume Ploussard; Shahrokh F Shariat; Alice Dragomir; Luis A Kluth; Evanguelos Xylinas; Alexandra Masson-Lecomte; Malte Rieken; Michael Rink; Kazumasa Matsumoto; Eiji Kikuchi; Tobias Klatte; Stephen A Boorjian; Yair Lotan; Florian Roghmann; Adrian S Fairey; Yves Fradet; Peter C Black; Ricardo Rendon; Jonathan Izawa; Wassim Kassouf
Journal:  Eur Urol       Date:  2013-10-09       Impact factor: 20.096

9.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

10.  Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.

Authors:  Mei Xue; Huan Pang; Xu Li; Huijin Li; Jingjing Pan; Wei Chen
Journal:  Cancer Sci       Date:  2015-12-11       Impact factor: 6.716

View more
  30 in total

Review 1.  Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Authors:  Giulia Brisotto; Roberto Guerrieri; Francesca Colizzi; Agostino Steffan; Barbara Montico; Elisabetta Fratta
Journal:  Methods Mol Biol       Date:  2021

2.  Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial-mesenchymal transition.

Authors:  Chuntao Tian; Ying Liu; Lingfei Xue; Dong Zhang; Xiaotong Zhang; Jing Su; Jiaohong Chen; Xiangke Li; Liuxing Wang; Shunchang Jiao
Journal:  Open Life Sci       Date:  2022-06-15       Impact factor: 1.311

Review 3.  Long non-coding RNAs in genitourinary malignancies: a whole new world.

Authors:  Ronan Flippot; Guillaume Beinse; Alice Boilève; Julien Vibert; Gabriel G Malouf
Journal:  Nat Rev Urol       Date:  2019-08       Impact factor: 14.432

4.  Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma.

Authors:  Zhiyuan Zhang; Sen Wang; Dongjian Ji; Wenwei Qian; Qingyuan Wang; Jie Li; Jiou Gu; Wen Peng; Tao Hu; Bing Ji; Yue Zhang; Shijia Wang; Yueming Sun
Journal:  Oncol Rep       Date:  2018-03-05       Impact factor: 3.906

5.  LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions.

Authors:  Cristina Barbagallo; Duilia Brex; Angela Caponnetto; Matilde Cirnigliaro; Marina Scalia; Antonio Magnano; Rosario Caltabiano; Davide Barbagallo; Antonio Biondi; Alessandro Cappellani; Francesco Basile; Cinzia Di Pietro; Michele Purrello; Marco Ragusa
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-02       Impact factor: 8.886

Review 6.  The Emerging Roles of Exosomes as EMT Regulators in Cancer.

Authors:  Hyunwoo Kim; Sungmin Lee; Eunguk Shin; Ki Moon Seong; Young Woo Jin; HyeSook Youn; BuHyun Youn
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

Review 7.  Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer.

Authors:  Alba Loras; Cristina Segovia; José Luis Ruiz-Cerdá
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

8.  BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.

Authors:  Liyao Gou; Mengyao Liu; Jing Xia; Qun Wan; Yayun Jiang; Shilei Sun; Min Tang; Lan Zhou; Tongchuan He; Yan Zhang
Journal:  Int J Mol Sci       Date:  2018-04-08       Impact factor: 5.923

9.  lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy.

Authors:  Jiheng Xu; Rui Yang; Xiaohui Hua; Maowen Huang; Zhongxian Tian; Jingxia Li; Hoi Yun Lam; Guosong Jiang; Mitchell Cohen; Chuanshu Huang
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-18       Impact factor: 8.886

Review 10.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.